As of March 23, 2026, the three largest insider holders of RMD are Michael J. Farrell (Chairman And Ceo, 466.22K shares), Robert Andrew Douglas (President And Coo, 250.53K shares), David Pendarvis (Chief Administrative Officer, 89.73K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Michael J. Farrell | Chairman And Ceo | 466,223 | 0 | 10 Mar, 2026 |
| Robert Andrew Douglas | President And Coo | 0 | 250,526 | 16 Aug, 2023 |
| David Pendarvis | Chief Administrative Officer | 89,729 | 0 | 06 Jun, 2023 |
| Brett Sandercock | Chief Financial Officer | 84,495 | 0 | 03 Mar, 2026 |
| James Hollingshead | President, Sleep Business | 76,721 | 0 | 01 Dec, 2021 |
| Peter C Farrell | 62,773 | 0 | 05 Mar, 2026 | |
| Justin Leong | Chief Product Officer | 29,028 | 0 | 21 Nov, 2025 |
| Rajwant Sodhi | President, Saas Business | 26,731 | 0 | 02 Sep, 2021 |
| Ronald R Taylor | 24,771 | 0 | 21 Nov, 2025 | |
| Richard Sulpizio | 17,796 | 0 | 21 Nov, 2024 | |
| Carol Burt | 0 | 14,892 | 24 May, 2024 | |
| Robert Andrew Douglas | President And Coo | 13,849 | 0 | 20 Nov, 2023 |
| Inc Resmed | 13,823 | 0 | 22 Nov, 2021 | |
| Harjit Gill | 10,940 | 0 | 24 Nov, 2025 | |
| Karen Drexler | 10,602 | 0 | 24 Nov, 2025 | |
| Lucile Blaise | President, Sleep Rc Business | 10,305 | 0 | 15 Nov, 2023 |
| Kaushik Ghoshal | Chief Commercial Officer, Saas | 9,725 | 0 | 11 Mar, 2025 |
| Michael J Rider | Global General Counsel | 9,691 | 0 | 05 Feb, 2026 |
| Kaushik Ghoshal | Chief Commercial Officer, Saas | 0 | 9,628 | 01 Nov, 2024 |
| Desney Tan | 6,002 | 0 | 24 Nov, 2025 | |
| John Hernandez | 5,118 | 0 | 24 Nov, 2025 | |
| Witte Jan De | 4,261 | 0 | 26 Nov, 2025 | |
| Christopher Delorefice | 2,423 | 0 | 21 Nov, 2025 | |
| Carol Burt | 2,156 | 0 | 24 Nov, 2025 | |
| Nicole Mowad-Nassar | 777 | 0 | 24 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 09 Mar, 2026 | Michael J. Farrell | ResMed Common Stock | A | 4,991 | $146.34 | 471,214 | D | M |
| 09 Mar, 2026 | Michael J. Farrell | ResMed Common Stock | D | 4,991 | $251.03 | 466,223 | D | S |
| 09 Mar, 2026 | Michael J. Farrell | ResMed Common Stock Options | D | 4,991 | $0.00 | 39,930 | D | M |
| 04 Mar, 2026 | Peter C Farrell | ResMed Common Stock | D | 2,000 | $260.22 | 62,773 | D | S |
| 02 Mar, 2026 | Brett Sandercock | ResMed Common Stock | D | 1,000 | $254.30 | 84,495 | D | S |
| 09 Feb, 2026 | Michael J. Farrell | ResMed Common Stock | A | 4,991 | $146.34 | 471,214 | D | M |
| 09 Feb, 2026 | Michael J. Farrell | ResMed Common Stock | D | 4,991 | $273.78 | 466,223 | D | S |
| 09 Feb, 2026 | Michael J. Farrell | ResMed Common Stock Options | D | 4,991 | $0.00 | 44,921 | D | M |
| 04 Feb, 2026 | Peter C Farrell | ResMed Common Stock | D | 2,000 | $251.31 | 64,773 | D | S |
| 04 Feb, 2026 | Michael J Rider | ResMed Common Stock | D | 50 | $260.00 | 9,691 | D | S |
| 02 Feb, 2026 | Brett Sandercock | ResMed Common Stock | D | 1,000 | $257.03 | 85,495 | D | S |
| 07 Jan, 2026 | Peter C Farrell | ResMed Common Stock | D | 2,000 | $248.83 | 66,773 | D | S |
| 07 Jan, 2026 | Michael J. Farrell | ResMed Common Stock | A | 4,991 | $146.34 | 471,214 | D | M |
| 07 Jan, 2026 | Michael J. Farrell | ResMed Common Stock | D | 4,991 | $248.46 | 466,223 | D | S |
| 07 Jan, 2026 | Michael J. Farrell | ResMed Common Stock Options | D | 4,991 | $0.00 | 49,912 | D | M |
| 02 Jan, 2026 | Michael J Rider | ResMed Common Stock | D | 50 | $241.75 | 9,741 | D | S |
| 02 Jan, 2026 | Brett Sandercock | ResMed Common Stock | D | 1,000 | $241.75 | 86,495 | D | S |
| 08 Dec, 2025 | Michael J. Farrell | ResMed Common Stock | A | 4,991 | $146.34 | 471,214 | D | M |
| 08 Dec, 2025 | Michael J. Farrell | ResMed Common Stock | D | 4,991 | $251.41 | 466,223 | D | S |
| 08 Dec, 2025 | Michael J. Farrell | ResMed Common Stock Options | D | 4,991 | $0.00 | 54,903 | D | M |